Early clinical response in patients with migraine in treatment with anti-CGRP monoclonal antibodies: a possible "loading dose" effect?

被引：0
|
作者：
Ceccardi, Giulia
di Cola, Francesca Schiano
Bolchini, Marco
Di Pasquale, Michele
Rao, Renata
Padovani, Alessandro
机构：
[1] ASST Spedali Civili, Neurol Unit, Brescia, Italy
[2] ASST Spedali Civili, Headache Ctr, Dipartimento Continuita Cura & Fragilita, Brescia, Italy
[3] Univ Brescia, Brescia, Italy
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [1] Late Response to Anti-CGRP Monoclonal Antibodies in Migraine
    Barbanti, Piero
    Aurilia, Cinzia
    Egeo, Gabriella
    Torelli, Paola
    Proietti, Stefania
    Cevoli, Sabina
    Bonassi, Stefano
    NEUROLOGY, 2023, 101 (11) : 482 - 488
  • [2] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [3] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Fred Cohen
    Hsiangkuo Yuan
    E. M. G. DePoy
    Stephen D. Silberstein
    Neurotherapeutics, 2022, 19 : 922 - 930
  • [4] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
    Hennessy, Elise
    Salim, Amira
    Biswas, Sudipa
    Suneja, Aarushi
    Mays, Maryann
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [5] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Cohen, Fred
    Yuan, Hsiangkuo
    DePoy, E. M. G.
    Silberstein, Stephen D.
    NEUROTHERAPEUTICS, 2022, 19 (03) : 922 - 930
  • [6] Synergism of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in the treatment of migraine
    Hennessy, E.
    Salim, A.
    Biswas, S.
    Sonneborn, C.
    Hogue, O.
    Suneja, A.
    Mays, M.
    Ahmed, Z.
    Mata, I
    HEADACHE, 2023, 63 : 170 - 171
  • [7] Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies
    Khodavirdi, Ani C.
    Multani, Jasjit K.
    Oh, Sam S.
    Vuvu, Fiston
    Bensink, Mark E.
    Stockl, Karen M.
    Hawkins, Kevin
    Chiang, Chia-Chun
    Green, A. Laine
    Tepper, Stewart J.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [8] Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine
    Van der Arend, Britt W. H.
    Van Veelen, Nancy
    De Ruijter, Joelle E. T.
    Olsen, Michael H.
    MaassenVanDenBrink, Antoinette
    Terwindt, Gisela M.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [9] Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Caronna, Edoardo
    Gallardo, Victor Jose
    Egeo, Gabriella
    Vazquez, Manuel Millan
    Castellanos, Candela Nieves
    Membrilla, Javier A.
    Vaghi, Gloria
    Rodriguez-Montolio, Joana
    Fabra, Neus Fabregat
    Sanchez-Caballero, Francisco
    Sanchez, Alex Jaimes
    Munoz-Vendrell, Albert
    Oliveira, Renato
    Garate, Gabriel
    Gonzalez-Osorio, Yesica
    Guisado-Alonso, Daniel
    Ornello, Raffaele
    Thunstedt, Cem
    Fernandez-Lazaro, Iris
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Torelli, Paola
    Aurilia, Cinzia
    Pere, Raquel Lamas
    Castrillo, Maria Jose Ruiz
    De Icco, Roberto
    Sances, Grazia
    Broadhurst, Sarah
    Ong, Hui Ching
    Garcia, Andrea Gomez
    Campoy, Sergio
    Sanahuja, Jordi
    Cabral, Goncalo
    Blasco, Isabel Beltran
    Waliszewska-Prosol, Marta
    Pereira, Liliana
    Layos-Romero, Almudena
    Luzeiro, Isabel
    Dorado, Laura
    Escudero, Maria Rocio Alvarez
    May, Arne
    Lopez-Bravo, Alba
    Martins, Isabel Pavao
    Sundal, Christina
    Irimia, Pablo
    Ros, Alberto Lozano
    Gago-Veiga, Ana Beatriz
    Juanes, Fernando Velasco
    Ruscheweyh, Ruth
    Sacco, Simona
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (10): : 927 - 937
  • [10] Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
    Pellesi, Lanfranco
    Guerzoni, Simona
    Pini, Luigi Alberto
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (06): : 534 - 547
12345